back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-20 20:18 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Holder: Ken Brownell Investments Limited (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$59,500
+119,000 vol $0.50 each |
119,000 | |
| Filed 2026-08-20 20:17 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Holder: Ken Brownell Investments Limited (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-20 20:15 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Holder: Ken Brownell Investments Limited (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-20 20:13 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Holder: Ken Brownell Investments Limited (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$99,960
+238,000 vol $0.42 each |
738,000 | |
| Filed 2025-11-13 19:12 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$59,500
+119,000 vol $0.50 each |
||
| Filed 2025-11-13 19:03 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Brownell, Kenneth Alva
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$99,960
+238,000 vol $0.42 each |
||
| Filed 2026-07-15 16:14 Tx date 2026-07-14 |
$PCRX
PharmaCorp Rx Inc. |
Simpson, Alan Arthur
4 - Director of Issuer
Holder: Noah Waters Holdings Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$88,399
+173,333 vol $0.51 each |
4,673,333 | |
| Filed 2026-07-15 16:11 Tx date 2026-07-14 |
$PCRX
PharmaCorp Rx Inc. |
Dale, Paul Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$88,399
+173,333 vol $0.51 each |
411,433 | |
| Filed 2026-07-15 16:07 Tx date 2026-07-14 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$88,399
+173,333 vol $0.51 each |
244,843 | |
| Filed 2026-07-15 16:02 Tx date 2026-07-14 |
$PCRX
PharmaCorp Rx Inc. |
Brown, Grady Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$88,200
+172,942 vol $0.51 each |
1,080,682 | |
| Filed 2026-07-15 12:17 Tx date 2026-07-09 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$10,411
+17,353 vol $0.60 each |
47,153 | |
| Filed 2026-07-15 12:16 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
29,800 | ||
| Filed 2026-07-15 12:15 Tx date 2026-07-09 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$10,411
+17,353 vol $0.60 each |
76,878 | |
| Filed 2026-07-15 12:10 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
59,525 | ||
| Filed 2026-07-15 11:40 Tx date 2026-07-09 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$17,700
+34,706 vol $0.51 each |
344,306 | |
| Filed 2026-07-15 11:37 Tx date 2026-07-09 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$17,700
+34,706 vol $0.51 each |
403,756 | |
| Filed 2026-03-25 15:18 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2026-03-25 14:59 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2026-03-25 14:59 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Dumont, James
4 - Director of Issuer
Holder: Saralex Enterprise Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-25 14:58 Tx date 2024-06-06 |
$PCRX
Proton Capital Corp. |
Dumont, James
4 - Director of Issuer
Holder: JDUMONT005 (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|